U.S. patent application number 11/981627 was filed with the patent office on 2008-07-24 for mitigation of photodamage in analytical reactions.
This patent application is currently assigned to Pacific Biosciences of California, Inc.. Invention is credited to John Eid, Devon Murphy, Geoffrey Otto, Stephen Turner.
Application Number | 20080176241 11/981627 |
Document ID | / |
Family ID | 38092834 |
Filed Date | 2008-07-24 |
United States Patent
Application |
20080176241 |
Kind Code |
A1 |
Eid; John ; et al. |
July 24, 2008 |
Mitigation of photodamage in analytical reactions
Abstract
Compositions, devices, systems and methods for reducing and/or
preventing photodamage of one or more reactants in illuminated
analytical reactions by one or more of incorporating photodamage
mitigating agents within the reaction mixture and/or interrogating
different observation regions of the reaction mixture for a period
that is less than a photodamage threshold period.
Inventors: |
Eid; John; (Palo Alto,
CA) ; Murphy; Devon; (Mountain View, CA) ;
Otto; Geoffrey; (Santa Clara, CA) ; Turner;
Stephen; (Menlo Park, CA) |
Correspondence
Address: |
MORGAN, LEWIS & BOCKIUS LLP (SF)
One Market, Spear Street Tower, Suite 2800
San Francisco
CA
94105
US
|
Assignee: |
Pacific Biosciences of California,
Inc.
Menlo Park
CA
|
Family ID: |
38092834 |
Appl. No.: |
11/981627 |
Filed: |
October 31, 2007 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
11293040 |
Dec 2, 2005 |
|
|
|
11981627 |
|
|
|
|
Current U.S.
Class: |
435/6.11 ;
435/28; 435/4 |
Current CPC
Class: |
G01N 33/582 20130101;
A61K 38/446 20130101; A61K 38/063 20130101; A61K 38/443
20130101 |
Class at
Publication: |
435/6 ; 435/4;
435/28 |
International
Class: |
C12Q 1/68 20060101
C12Q001/68; C12Q 1/00 20060101 C12Q001/00; C12Q 1/28 20060101
C12Q001/28 |
Goverment Interests
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH
[0002] A portion of this invention was made with government funding
under NHGRI Grant No. 1 R01 HG003710-01, and the government has
certain rights in the invention.
Foreign Application Data
Date |
Code |
Application Number |
Dec 1, 2006 |
US |
PCT/US06/46025 |
Claims
1-28. (canceled)
29. A method of performing an illuminated reaction, comprising:
providing a substrate having a reaction mixture disposed thereon,
wherein the reaction mixture comprises a first reactant, a second
reactant and a photodamage mitigating agent, wherein the
photodamage mitigating agent reduces an amount of photodamage to
the first reactant resulting from interaction of the first reactant
with the second reactant under excitation illumination that would
occur in the absence of the photodamage mitigating agent; and
illuminating the reaction mixture on the substrate, with an
excitation illumination.
30. The method of claim 29, further comprising the step of
monitoring a reaction between the first and second reactant while
illuminating the reaction mixture.
31. A method of performing an enzyme reaction, comprising:
providing an enzyme within a first observation region; contacting
the enzyme with a fluorescent or fluorogenic substrate for the
enzyme; and directing an excitation radiation at and detecting
signals from the first observation region for a period that is less
than a photodamage threshold period.
32. The method of claim 31, comprising repeating the providing,
contacting and directing steps with at least a second observation
region.
33. A method of monitoring a base extension reaction, comprising:
providing a polymerase enzyme within a first observation region;
contacting the polymerase with at least a first fluorescent or
fluorogenic nucleotide analog; and monitoring a fluorescent signal
emitted from the first observation region in response to
illumination with excitation radiation for a period that is less
than a photodamage threshold period.
34. (canceled)
35. A method of performing an enzyme reaction, comprising:
providing an enzyme within an observation region; contacting the
enzyme with a fluorescent or fluorogenic substrate for the enzyme
under excitation illumination, in the presence of at least a first
photodamage mitigating agent.
36. A method of monitoring a base extension reaction, comprising:
providing a polymerase enzyme within an observation region;
contacting the polymerase with at least a first fluorescent or
fluorogenic nucleotide analog in the presence of at least a first
photodamage mitigating agent; and monitoring a fluorescent signal
emitted from the observation region in response to illumination
with excitation radiation.
37. A method of monitoring a reaction mixture comprising at least a
first enzyme and a fluorescent or fluorogenic substrate for the
first enzyme, comprising directing an excitation radiation at a
first observation region for a first period that is less than a
photodamage threshold period.
38. The method of claim 37, further comprising redirecting the
excitation radiation at a second observation region after the first
period, for a second period that is less than the photodamage
threshold period.
39. The method of claim 29, wherein the photodamage mitigating
agent is selected from oxygen scavenging or quenching reagents and
triplet state quenchers.
40. The method of claim 29, wherein the photodamage mitigating
agent is selected from the group of superoxide dimutase, glucose
oxidase/catalase (GO/Cat), glutathione peroxidase, ergothioneine,
methionine, cysteine, beta-dimethyl cysteine,
mercaptopropionylglycine, MESNA, glutathione, dithiothreitol,
N-acetyl cysteine, captopril, lycopene, gamma-carotene,
astazanthin, canthazanthin, alpha-carotene; beta-carotene, bixin,
zeaxanthin, lutein, bilirubin, biliverdin, tocopherols, polyene
dialdehydes, melatonin, .alpha.-tocopheryl succinate and its
analogs, and pyridoxinel and its derivatives, hydrazine
(N.sub.2H.sub.4), sodium sulfite (Na.sub.2SO.sub.3), and
hydroxylamine.
41. The method of claim 29, wherein the photodamage mitigating
agent is selected from the group consisting of ascorbic acid,
dithiothreitol (DTT), mercaptoethylamine (MEA),
.beta.-mercaptoethanol (BME), n-propyl gallate, p-phenylenediamene
(PPD), hydroquinone, sodium azide (NaN.sub.3), diazobicyclooctane
(DABCO).
42. The method of claim 29, wherein the photodamage mitigating
agent reduces an amount of photodamage to the first reactant
resulting from interaction of the first reactant with the second
reactant under excitation illumination that would occur in the
absence of the photodamage mitigating agent by at least 10%.
43. The method of claim 29, wherein the photodamage mitigating
agent reduces an amount of photodamage to the first reactant
resulting from interaction of the first reactant with the second
reactant under excitation illumination that would occur in the
absence of the photodamage mitigating agent by at least 20%.
44. The method of claim 29, wherein the photodamage mitigating
agent reduces an amount of photodamage to the first reactant
resulting from interaction of the first reactant with the second
reactant under excitation illumination that would occur in the
absence of the photodamage mitigating agent by at least 50%.
45. The method of claim 29, wherein the photodamage mitigating
agent reduces an amount of photodamage to the first reactant
resulting from interaction of the first reactant with the second
reactant under excitation illumination that would occur in the
absence of the photodamage mitigating agent by at least 90%.
46. The method of claim 29, wherein the first reactant comprises a
nucleic acid polymerase, and the second reactant comprises a
fluorescently labeled nucleotide or nucleic acid.
47. The method of claim 46, wherein the polymerase enzyme is
immobilized on the substrate.
48. The method of claim 33, further comprising providing a
photodamage mitigating agent in the observation volume.
49. The method of claim 48, wherein the photodamage mitigating
agent is selected from superoxide dimutase, glucose
oxidase/catalase (GO/Cat), glutathione peroxidase, ergothioneine,
methionine, cysteine, beta-dimethyl cysteine,
mercaptopropionylglycine, MESNA, glutathione, N-acetyl cysteine,
captopril, lycopene, gamma-carotene, astazanthin, canthazanthin,
alpha-carotene, beta-carotene, bixin, zeaxanthin, lutein,
bilirubin, biliverdin, tocopherols, polyene dialdehydes, melatonin,
.alpha.-tocopheryl succinate and its analogs, and pyridoxinel and
its derivatives, hydrazine (N.sub.2H.sub.4), sodium sulfite
(Na.sub.2SO.sub.3), hydroxylamine, ascorbic acid, dithiothreitol
(DTT), mercaptoethylamine (MEA), .beta.-mercaptoethanol (BME),
n-propyl gallate, p-phenylenediamene (PPD), hydroquinone, sodium
azide (NaN.sub.3), diazobicyclooctane (DABCO).
50. The method of claim 35, wherein the photodamage mitigating
agent is selected from an oxygen scavenging reagent and a triplet
state quencher.
51. The method of claim 50, wherein the photodamage mitigating
agent is selected from superoxide dimutase, glucose,
oxidase/catalase (GO/Cat), glutathione peroxidase, ergothioneine,
methionine, cysteine, beta-dimethyl cysteine,
mercaptopropionylglycine, MESNA, glutathione, N-acetyl cysteine,
captopril, lycopene, gamma-carotene, astazanthin, canthazanthin,
alpha-carotene, beta-carotene, bixin, zeaxanthin, lutein,
bilirubin, biliverdin, tocopherols, polyene dialdehydes, melatonin,
.alpha.-tocopheryl succinate and its analogs, and pyridoxinel and
its derivatives, hydrazine (N.sub.2H.sub.4), sodium sulfite
(Na.sub.2SO.sub.3), hydroxylamine, ascorbic acid, dithiothreitol
(DTT), mercaptoethylamine (MEA), .beta.-mercaptoethanol (BME),
n-propyl gallate, p-phenylenediamene (PPD), hydroquinone, sodium
azide (NaN.sub.3), diazobicyclooctane (DABCO).
52. The method of claim 35, wherein the enzyme comprises a nucleic
acid polymerase.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation U.S. patent application
Ser. No. 11/293,040 filed Dec. 2, 2005, the full disclosure of
which is incorporated herein in its entirety for all purposes.
BACKGROUND OF THE INVENTION
[0003] The use of optically detectable labeling groups, and
particularly those groups having high quantum yields, e.g.,
fluorescent or chemiluminescent groups, is ubiquitous throughout
the fields of analytical chemistry, biochemistry and biology. In
particular, by providing a highly visible signal associated with a
given reaction, one can better monitor that reaction as well as any
potential effectors of that reaction. Such analyses are the basic
tools of life science research in genomics, diagnostics,
pharmaceutical research, and related fields.
[0004] To date, such analyses have generally been performed under
conditions where the amounts of reactants are so far in excess that
any adverse effects of the optical event would be unnoticed. For
example, such analyses based upon fluorescent labeling groups
generally require the use of an excitation radiation source
directed at the reaction mixture, to excite the fluorescent
labeling group, which is then separately detectable. However,
prolonged exposure of chemical and biochemical reactants to such
light sources, alone, or when in the presence of other components,
e.g., the fluorescent groups, can lead, potentially, to damage to
such reactants, e.g., proteins, enzymes, substrates, or the like.
As noted previously, however, the existing formats for such
reactions generally prevents any such effects from being
problematic, or even being noticed.
[0005] A variety of analytical techniques are being explored,
however, that deviate from the previous formats, such that
detrimental effects of such photodamage will have a more dramatic
impact on the operation of the given analysis. In particular, real
time analyses of reactions that include fluorescent reagents can
expose multiple different components to optical energy.
Additionally, reactions based upon increasingly smaller amounts of
reagents, e.g., in microfluidic or nanofluidic reaction vessels or
channels, or in "single molecule" analyses. As such, the present
invention is directed at methods and compositions that prevent or
mitigate to some extent, the adverse effects of such photodamage,
and also to processes that benefit from such methods and/or
compositions, among other useful processes and compositions.
BRIEF SUMMARY OF THE INVENTION
[0006] The present invention is generally directed to compositions,
devices, systems and methods for reducing and/or eliminating
photodamage and its effects in illuminated reactions, and
particularly those that utilize fluorescent and/or fluorogenic
reactants.
[0007] In at least a first aspect, the invention provides a
composition that comprises a first reactant, a second reactant, and
a photodamage mitigating agent, where interaction of the first
reactant with the second reactant under excitation illumination
causes photodamage to the first reactant in the absence of the
photodamage mitigating agent.
[0008] Relatedly, the invention further provides a composition that
comprises a confined enzyme, a substrate for said enzyme, wherein
interaction of the enzyme with the substrate under excitation
illumination causes photodamage to the first reactant in the
absence of a photodamage mitigating agent, and a photodamage
mitigating agent.
[0009] The invention also provides devices that comprise a
substrate having an observation region, a first reactant
immobilized within the observation region, a second reactant
disposed within the observation region, wherein interaction between
the first and second reactants under excitation illumination causes
photodamage to the first reactant, and a photodamage mitigating
agent disposed within the observation region.
[0010] The invention also provides methods of performing an
illuminated reaction, comprising providing a substrate having a
reaction mixture disposed thereon, wherein the reaction mixture
comprises a first reactant, a second reactant and a photodamage
mitigating agent, wherein the photodamage mitigating agent reduces
an amount of photodamage to the first reactant resulting from
interaction of the first reactant with the second reactant under
excitation illumination that would occur in the absence of the
photodamage mitigating agent. The reaction mixture is then
illuminated on the substrate, with an excitation illumination.
[0011] In additional aspects, the invention provides methods of
performing an enzyme reaction, comprising providing an enzyme
within a first observation region. The enzyme is contacted with a
fluorescent or fluorogenic substrate for the enzyme, and an
excitation radiation is directed at and signals are detected from
the first observation region for a period that is less than a
photodamage threshold period.
[0012] Similarly, in other aspects, the invention provides methods
of monitoring a base extension reaction, comprising providing a
polymerase enzyme within a first observation region, contacting the
polymerase with at least a first fluorescent or fluorogenic
nucleotide analog, and monitoring a fluorescent signal emitted from
the first observation region in response to illumination with
excitation radiation for a period that is less than a photodamage
threshold period.
[0013] The invention also includes a system for analyzing an
illuminated reaction that is susceptible to photodamage when
illuminated for a period longer than an photodamage threshold
period. The system typically comprises a substrate having reagents
for the reaction disposed thereon, a mounting stage supporting the
substrate and configured to receive the substrate, an optical train
positioned to be in optical communication with at least a portion
of the substrate to illuminate the portion of the substrate and
detect signals emanating therefrom, and a translation system
operably coupled to the mounting stage or the optical train for
moving one of the optical train and the substrate relative to the
other.
[0014] Also provided are methods of performing an enzyme reaction,
comprising providing an enzyme within an observation region, and
contacting the enzyme with a fluorescent or fluorogenic substrate
for the enzyme under excitation illumination, in the presence of at
least a first photodamage mitigating agent.
[0015] Other methods of the invention include methods of monitoring
a base extension reaction, comprising providing a polymerase enzyme
within an observation region, contacting the polymerase with at
least a first fluorescent or fluorogenic nucleotide analog in the
presence of at least a first photodamage mitigating agent, and
monitoring a fluorescent signal emitted from the observation region
in response to illumination with excitation radiation.
[0016] Also included are methods of monitoring a reaction mixture
comprising at least a first enzyme and a fluorescent or fluorogenic
substrate for the first enzyme, where the method comprises
directing an excitation radiation at a first observation region for
a first period that is less than a photodamage threshold
period.
BRIEF DESCRIPTION OF THE DRAWINGS
[0017] FIG. 1 is a schematic illustration of a proposed mechanism
of photodamage to DNA polymerase in template dependent synthesis
using fluorescent nucleotide analogs while under excitation
illumination.
[0018] FIG. 2A-2B are images of agarose gels of DNA synthesis
products made in the presence of fluorescent nucleotide analogs and
under selective illumination with laser excitation light. Shown are
products of synthesis reaction mixtures in the presence and absence
of different photodamage mitigating agents.
[0019] FIG. 3A-3C are images of DNA synthesized on a planar
substrate using fluorescent nucleotide analogs while being
selectively illuminated at the excitation wavelengths of the
fluorescent analogs. Shown are substrates subjected to the reaction
mixtures in the presence and absence of different photodamage
mitigating agents.
[0020] FIG. 4A-4B are images of arrays of zero mode waveguides
having immobilized DNA polymerase disposed in the waveguides, and
applied in template directed synthesis of DNA using fluorescent
nucleotide analogs, while being selectively illuminated with lasers
at the fluorescent analogs' excitation wavelengths.
[0021] FIG. 5 is a schematic illustration of a step and repeat
analysis method to avoid the impacts of excessive photodamage on
assay substrates.
[0022] FIGS. 6A and 6B provide a schematic comparison of a
non-overlapping step and repeat interrogation and a scan mode
interrogation.
[0023] FIG. 7 is a schematic illustration of a system for carrying
out certain aspects of the invention.
DETAILED DESCRIPTION OF THE INVENTION
[0024] The present invention is generally directed to methods of
performing improved illuminated reactions, and particularly
reactions that employ fluorescent or fluorogenic reactants, that
mitigate the effects of and/or reduce photodamage to the various
reactants present in such reactions. The invention includes methods
for preventing or reducing such photodamage as well as methods for
mitigating the impacts such photodamage might have on an overall
analysis, as well as combinations of these.
[0025] While the invention is generally applicable to any of a
variety of optical assays that require substantial illumination
and/or photoactivated conversion or excitation of chemical groups,
e.g., fluorophores, it finds greatest utility in analyses that
utilize very limited concentrations of reactants that might be
subject to photodamage. As will be appreciated, in such reagent
limited analyses, any degradation of a critical reagent will
dramatically impact the analysis, by further limiting the
reagent.
[0026] One particularly apt example of analyses that benefit from
the invention are single molecule biological analyses, including,
inter alia, single molecule nucleic acid sequencing analyses,
single molecule enzyme analyses, hybridization assays, e.g.,
antibody assays, nucleic acid hybridization assays, and the like,
where the reagents of primary import are subjected to prolonged
illumination with relatively concentrated light sources, e.g.,
lasers or other concentrated light sources, i.e., mercury, xenon,
halogen or other lamps, in an environment where
photoconversion/excitation is occurring, with its associated
generation of products.
[0027] With reference to nucleic acid analyses, it has been
observed that in template directed synthesis of nucleic acids using
fluorescent nucleotide analogs as the substrate, that prolonged
illumination under such conditions yields substantial degradation
in the ability of the polymerase to synthesize such DNA (See FIG.
3A, and Example 1). Damage or even inactivation of polymerase
enzymes can seriously detract from the ability of the polymerase to
process longer strands of nucleic acids. This reduction in
processivity of the enzyme, in turn, leads to a reduction in read
lengths for sequencing processes that identify sequence
constituents based upon their incorporation into the nascent
strand. As is appreciated in the art of genetic analysis, the
length of contiguous reads of sequence directly impacts the ability
to assemble genomic information from segments of genomic DNA. A
proposed mechanism for this photodamage is shown in FIG. 1. As
shown, a fluorophore excited by exposure to electromagnetic
radiation at an excitation wavelength can transition into a triplet
state. Subsequent relaxation of the triplet state fluorophore can
then lead to generation of reactive oxygen species, which can, in
turn, damage one or both of the fluorophore or the enzyme
processing the fluorophore, e.g., the polymerase. Accordingly,
oxygen scavengers and/or reducing agents are included to prevent
the formation of reactive oxygen.
[0028] In general terms, the invention is generally directed to the
performance of illuminated reaction analyses, where such analyses
are illuminated for an amount of time that still permits the
effective performance of the analysis. In particularly preferred
aspects, illuminated analysis refers to an analytical reaction that
is occurring while being illuminated, e.g., with excitation
radiation, so as to evaluate the production, consumption and/or
conversion of luminescent, e.g., fluorescent reactants and/or
products As used herein, the amount of time an illuminated analysis
may be carried out before photodamage so substantially impacts the
reactants to render the analysis non-useful, is referred to as the
photodamage threshold period. In terms of the invention, the
photodamage threshold period is preferably that period of
illuminated analysis during which such photodamage occurs so as to
reduce the rate of the subject reaction by at least 20% over the
same reaction in the absence of such illumination, more preferably,
more than 50%, and in some cases, more than 90%, e.g., causing a
90% reduction in the reaction rate of the system, or a 90%
reduction in the amount of product produced during a given time
frame. It is an object of the invention to perform an illuminated
analysis within the photodamage threshold period. This is generally
accomplished in alternative ways. First, performing a given
reaction within the foregoing parameters and in accordance with the
invention or aspects thereof, may include performing the reaction
for a period of time that is less than the photodamage threshold
period. Second, the reaction may be configured to increase the
length of the photodamage threshold period, or third, it may
include a combination of these approaches.
[0029] As will be appreciated, the photodamage sought to be
prevented by the methods and compositions of the invention is not
merely photodamage to fluorescent reagents, e.g., photobleaching,
but is instead directed to prevention or reduction of the
downstream effects of such photodamage to other reagents that are
of limited quantity in a reaction mixture, and as such, their
limited presence is more greatly impacted by even slight losses due
to photodamage, and particularly reactive proteins or enzymes,
which, without being bound to a theory of operation, may include
damage to the enzymes or reactive proteins or irreversible
interactions between such enzymes or proteins and the photodamaged
reagents. As suggested by the foregoing, photodamage generally
refers to an alteration in a given reagent, reactant or the like,
that causes such reagent to have altered functionality in a desired
reaction, e.g., reduced activity, reduced specificity, or a reduced
ability to be acted upon, converted, or modified, by another
molecule, that results from, either directly or indirectly, a
photo-induced reaction, e.g., a photo-induced reaction creates a
damaged reactant that interacts with and causes damage to one or
more other reactants. Typically, such photoreaction directly
impacts either the reactant of interest, e.g., direct photodamage,
or impacts a reactant within one, two or three reactive steps of
such reactant of interest.
[0030] As generally referred to herein, such limited quantity
reagents or reactants may be present in solution, but at very
limited concentrations, e.g., less than 200 nM, in some cases less
than 10 nM and in still other cases, less than 10 pM. In preferred
aspects, however, such limited quantity reagents or reactants refer
to reactants that are immobilized, or otherwise confined within a
given area, so as to provide limited quantity of reagents in that
given area, and in certain cases, provide small numbers of
molecules of such reagents within that given area, e.g., from 1 to
1000 individual molecules, preferably between 1 and 10 molecules.
As will be appreciated, photodamage of immobilized reactants in a
given area will have a substantial impact on the reactivity of that
area, as other, non-damaged reactants are not free to diffuse into,
and mask the damage effects.
[0031] While researchers have provided methods and compositions for
limiting photodamage to fluorophores, the negative impacts of
downstream photodamage to enzymatic systems in the presence of
and/or resulting from photodestruction of fluorescent reagents has
not been readily recognized or addressed. For ease of discussion,
the detrimental impact of the photodamage event, whether resulting
from actual damage to a given reagent or from interaction with a
damaged reagent, is generally referred to herein as
photodamage.
I. PREVENTION OF PHOTODAMAGE
[0032] In a first aspect, the invention is directed to methods and
compositions that reduce the amount of photodamage that is done to
one or more non-fluorescent reactants during illumination, e.g.,
with an excitation radiation source. In particular, compositions
are provided that yield a reduction in the level of photodamage (or
an increase in the photodamage threshold period) as compared to
such reactions in the absence of such compositions. As used herein,
the components of such compositions that provide such effects are
generally referred to as photodamage mitigating agents. In
particular, photodamage mitigating agents are provided in the
context of the analytical reaction to reduce the level of
photodamage (and/or increase the photodamage threshold period),
that would otherwise have occurred but for the presence of the
photodamage mitigating agent.
[0033] Again, the definition of an agent as a photodamage
mitigating agent is generally reflective of the impact that such
agent has on the actual photodamage event or the downstream impacts
of that damage. As such, a photodamage mitigating agent may prevent
photodamage of one or more reagents, or it may mitigate the impact
that a photodamaged reagent may have on a particular, limited
reagent in the reaction of interest. By way of example, an agent
that blocks a detrimental interaction between a photodamaged
fluorescent compound and a critical enzyme component would still be
referred to as a photodamage mitigating agent, regardless of the
fact that it did not prevent the initial photodamage to the
fluorescent reagent.
[0034] Measurements of reduction of photodamage as a result of
inclusion or treatment with a photodamage mitigating agent may be
characterized as providing a reduction in the level of photodamage
over an untreated reaction. Further, characterization of a
reduction in photodamage generally utilizes a comparison of
reaction rates, e.g., enzyme activity, and/or a comparison of the
photodamage threshold period, between a treated reaction mixture
and an untreated reaction mixture.
[0035] In the case of the present invention, the inclusion of
photodamage mitigating agent(s) of the invention generally results
in a reduction of photodamage of one or more reactants in a given
reaction, as measured in terms of prevented loss of reactivity,
e.g., enzyme activity, in the system, of at least 10%, preferably,
greater than 20%, and more preferably, greater than about a 50%
reduction, and in many cases greater than a 90% and up to and
greater than 99% reduction in such photodamage. By way of
illustration, and purely for the purpose of example, when referring
to reduction in photodamage as a measure of enzyme activity in the
presence and absence of the photodamage mitigating agent, if a
reaction included a reaction mixture having 100 units of enzyme
activity that would, in the absence of a photodamage mitigating
agent, and following illuminated analysis, yield a reaction mixture
having only 50 units of activity, then a 10% reduction in
photodamage would yield a final reaction mixture of 55 units (e.g.,
10% of the 50 units otherwise lost, would no longer be lost).
[0036] Without being bound to a particular theory or mechanism of
operation, it is believed that at least one cause of photo-induced
damage to enzyme activity, particularly in the presence of
fluorescence reagents, results from the direct interaction of the
enzyme with photodamaged fluorescent reagents. Further, it is
believed that this photodamage of the fluorescent reagents (and
possibly additional damage to the enzyme) is at least partially
mediated by reactive oxygen species that are generated during the
relaxation of triplet state fluorophores in the presence of
molecular oxygen.
[0037] Accordingly, in at least a first aspect, the present
invention is directed to the inclusion within the illuminated
reaction mixture of one or more agents that function to block or
otherwise minimize the pathways that lead to such photodamage. Such
agents include reducing agents or anti-fade agents that prevent the
formation of the triplet state fluorophores (also referred to as
triplet state quenchers), as well as oxygen scavenging agents, that
remove oxygen and reactive oxygen species from the reaction
mixture, thus preventing downstream damage to enzymes within the
system.
[0038] A variety of reducing agents or anti-fade agents may be used
as triplet state quenchers, including, for example, ascorbic acid,
dithiothreitol (DTT), mercaptoethylamine (MEA),
.beta.-mercaptoethanol (BME), n-propyl gallate, p-phenylenediamene
(PPD), hydroquinone, sodium azide (NaN.sub.3), diazobicyclooctane
(DABCO), as well as commercially available anti fade agents, such
as Fluoroguard (available from BioRad Laboratories, Inc., Hercules,
Calif.), Citifluor antifadants (Citifluor, Ltd., London, UK),
ProLong, SlowFade, and SlowFade Light (Invitrogen/Molecular Probes,
Eugene, Oreg.).
[0039] Likewise, a number of singlet oxygen quenchers may be used
to eliminate or reduce reactive oxygen species, including, for
example, enzymatic systems, e.g., superoxide dimutase, glucose
oxidase/catalase (GO/Cat), glutathione peroxidase, or combinations
of these with other enzymes, or thiol based quenchers e.g.
ergothioneine, methionine, cysteine, beta-dimethyl cysteine
(penicillamine), mercaptopropionylglycine, MESNA, glutathione,
dithiothreitol (as noted above for a reducing agent), N-acetyl
cysteine and captopril (See, e.g., Biochem Soc. Trans. 1990
December; 18(6): 1054-6). Also, biological singlet oxygen quenchers
may be employed such as lycopene, gamma-carotene, astazanthin,
canthazanthin, alpha-carotene, beta-carotene, and its analogs (See,
e.g., Carcinogenesis vol. 18 no. 1 pp. 89-92, 1997), bixin,
zeaxanthin, lutein, bilirubin, biliverdin, and tocopherols (See,
e.g., Biochem Soc Trans. 1990 December; 18(6): 1054-6 ref.) as well
as polyene dialdehydes (Carcinogenesis vol. 18 no. 1 pp. 89-92,
1997) melatonin, vitamins E (.alpha.-tocopheryl succinate and its
analogs) and B.sub.6 (pyridoxinel and its derivatives). Other
chemical oxygen scavengers are also available, e.g., hydrazine
(N.sub.2H.sub.4), sodium sulfite (Na.sub.2SO.sub.3), hydroxylamine,
glutathione, and N-acetylcysteine, and the like. In addition to the
foregoing, in many cases, the amount of singlet oxygen quenchers or
scavengers may be reduced or eliminated by physically excluding
oxygen from the reaction of interest by, e.g., degassing reagents,
perfusion with inert gases, or the like.
[0040] In accordance with the present invention, photodamage
mitigating agents may generally be provided as a component of the
reaction mixture, either through addition as an additive, either
liquid or solid, or through predisposition and/or immobilization of
the photodamage mitigating agents within the region where the
reaction is taking place. By way of example, in cases where the
reaction of interest is confined to a particular region or
location, it may be desirable to immobilize or otherwise localize
the photodamage mitigating agents within or proximal to that
region. Likewise, where photodamage mitigating agent comprises
cooperatively functioning components, e.g., dual enzyme systems, it
may again be desirable to localize such components relative to each
other, as well as to the reaction of interest.
II. MITIGATION OF PHOTODAMAGE IMPACTS
[0041] In contrast and/or in addition to the use of photodamage
mitigating agents, the present invention also provides methods of
mitigating the impact of photodamage on the results of a given
analytical operation by only interrogating a reaction mixture,
e.g., detecting fluorescent emission, during such portion of the
illumination period before which excessive photodamage has
occurred. This approach is particularly useful in the optical
interrogation of reactions where components of the reaction that
are susceptible to photodamage are spatially confined on an assay
plate or substrate, either through the presence of structural
confinements and/or through immobilization of the components.
Examples of such confined reagents include surface immobilized or
localized reagents, e.g., surface immobilized or associated
enzymes, antibodies, etc. that are interrogated upon the surface,
e.g., through fluorescence scanning microscopy or scanning confocal
microscopy, total internal reflectance microscopy or fluorometry,
surface imaging, or the like.
[0042] As used herein, a substrate may comprise any of a variety of
formats, from planar substrates, e.g., glass slides or planar
surfaces within a larger structure, e.g., a multi-well plates such
as 96 well, 384 well and 1536 well plates or regularly spaced
micro- or nano-porous substrates, or such substrates may comprise
more irregular porous materials, such as membranes, aerogels,
fibrous mats, or the like, or they may comprise particulate
substrates, e.g., beads, spheres, metal or semiconductor
nanoparticles, or the like. In addition, for purposes of discussion
herein, whether a particular reagent is confined by virtue of
structural barriers to its free movement, or is chemically tethered
or immobilized to a surface of a substrate, it will be described as
being "confined".
[0043] For example, in interrogating an enzyme reaction where such
photodamage can occur and where the enzyme is immobilized upon a
substrate surface, prolonged exposure of a particular region will
result in photodamage to or "burning in" of the enzyme immobilized
within that region. In a number of cases, a selected region of a
substrate, including the reaction of interest will be interrogated.
For purposes of discussion, such region is termed an "observation
region."
[0044] In accordance with the present invention, the "burn in" or
at least the effects of such burn in, are reduced or eliminated by
illuminating and collecting emission signals from a different
observation region. For ease of discussion, the action of both
illuminating and collecting emission signals from a reaction of
interest, or a particular observation region in which a reaction of
interest is taking place, is referred to as interrogating that
reaction and/or that region. As will be appreciated, interrogating
a new observation region of a substrate will constitute newly
illuminating a region and collecting emission signals from that
newly illuminated region. Rephrased, as long as one is
interrogating a newly illuminated region, whether the burned region
is still being illuminated is not of major import, unless one is
desirous of returning to interrogate that region at a later
time.
[0045] In addition to the advantages of reducing photodamage, the
process of interrogating different regions of a substrate over time
also provides benefits of being able to interrogate larger
substrate areas with a given light source than would have otherwise
been possible without modifying the nature of the illumination,
e.g., expanding a laser spot size by changing the illumination
angle, e.g., to provide an elongated laser spot size (See, e.g.,
U.S. Pat. No. 6,881,312, incorporated herein by reference in its
entirety for all purposes), or passing the illumination through an
optical train that alters the shape of the incident light spot on
the substrate, e.g., providing a cylindrical lens to provide the
illumination in a line format, or otherwise refocusing the
illumination to provide an expanded spot size or dimension.
Notwithstanding the foregoing, it will be appreciated that the
present invention is optionally combined with such optics that
provide an expanded illumination area, that is optionally used in
addition to processes where such expanded illumination profile is
then moved over the substrate to interrogate different regions of
the substrate over time. FIG. 5 illustrates the movement of an
interrogation spot region over a substrate upon which a reaction of
interest is being carried out, over time, to interrogate different
regions of a substrate. As will be appreciated, used of a linear
illumination spot over the substrate would more rapidly illuminate
larger areas of the substrate than the circular spot shown in FIG.
5. As shown in FIG. 5, the exemplary substrate comprises a
plurality of arrays of smaller structural confinements (that also
function as optical confinements in the form of zero mode
waveguides), where each array or subset of arrays are included
within a separate structural confinement, e.g., a well in a
multiwell substrate or plate. As will be appreciated, the
interrogation function typically is carried out over a given region
for a prolonged period of time that is not longer than the
photodamage threshold period. Typically, this will be for greater
than 10 seconds, preferably greater than 1 minute, more preferably
greater than 5 minutes, greater than 10 minutes, greater than 20
minutes, and in some cases, greater than 2 hours or greater than 3
or more hours, but still less than the photodamage threshold
period.
[0046] In addition to gaining additional interrogation area by
moving the interrogation region over the area of the substrate, the
ability to move that region, also provides an ability to adjust the
mechanical interfaces with the substrate in a particular system or
apparatus, so as to make regions available for interrogation that
may have been otherwise un-interrogatable in the particular system
or apparatus. In particular, in a typical substrate analysis
set-up, a substrate to be analyzed is fixed upon an analysis stage
where portions of that substrate may be obscured from interrogation
by the mounting structure of the analysis stage, e.g., clips,
support structures, or the like. In accordance with certain aspects
of the invention, however, the movement of the interrogation region
provides the ability to alter, over time, the portions of the
substrate that are obscured by the mounting structures. In a first
example, rather than moving the optical train that provides
illumination to a given region of the substrate, the substrate may
be moved relative to the interrogation optics. This may be
accomplished using any of a variety of manipulation hardware or
robotic set-ups. For example, a stepper/feeder apparatus is used
that steps the substrate through the interrogation zone of the
optical train in a precise fashion. Such precise feeder apparatus'
are well known in high performance printing technologies, as well
as in translational robotics used in the semiconductor industry,
e.g., in both analytical and manufacturing applications. Such
stepper feeders may include a roller or wheel assembly that
contacts an upper surface of the overall substrate, and is rotated
to provide motive force to the substrate in a precise fashion, to
feed that substrate through the interrogation zone of the optical
train. In alternative aspects robotic systems may be used to
pick-up and re-orient a given substrate in order to interrogate
different regions of the substrate surface, or make a previously
inaccessible region of the substrate accessible. Such robotic
systems are generally available from, e.g., Beckman, Inc., Tecan,
Inc., Caliper Life Sciences, and the like.
[0047] In accordance with the invention, a reaction of interest
within a first observation region is interrogated for a time period
that is less than a photodamage threshold period, as set forth
elsewhere herein, and then the reaction of interest in a second,
different observation region is interrogated. In accordance with
the present invention, the observation typically includes confined
reagents that are susceptible to photodamage. As such, an
observation region may include an area of a planar or other
substrate surface upon which are immobilized reagents, e.g.,
enzymes. Alternatively, the observation region may include a
physical confinement that constrains the reagents that are
susceptible to photodamage, including, e.g., microwells, nanowells,
planar surfaces that include hydrophobic barriers to confine
reagents. As noted above, the present invention is particularly
applicable to observation regions in which the damage susceptible
reagents are present at concentrations or levels that photodamage
greatly impacts the reaction progress. This is particularly the
case in immobilized reaction systems where additional, excess
amounts of reagents can not be provided in a bulk solution to
obscure the impact of any damaged reagents.
[0048] The sequential interrogation of different observation
regions may generally be repeated a large number of times, e.g.,
more than 10, more than 100 more than 1000, or even more than
10,000 times, so long as observation regions remain. The
availability of multiple regions is generally limited only by the
size of a discrete observation region, which may be defined by one
or more of the nature and dimensions of any structural confinements
used, and the illumination spot size, and the overall area of the
analytical substrate. In general, this method of stepping the
interrogation region to another, preferably adjacent region, and
repeating the interrogation process is generally referred to as a
"step and repeat" process.
[0049] Although described as a "step and repeat" method, in some
embodiments where the interrogation region is moved across a
substrate, that movement is not step-wise and iterative, but
instead constitutes a continuous motion, substantially continuous
motion or a stepped movement or iterative motion whereby each
iterative step interrogates a new region that overlaps with some
portion of the previously interrogated region or of the
interrogation region across the substrate. In particular, a
substrate may be moved continuously through an interrogation zone
of an optical system, whereby the interrogation region moves
continuously across the substrate being interrogated (in a "scan
mode"). In accordance with preferred aspects, the speed of movement
of the interrogation region is dictated by the amount of time a
given reaction zone, e.g., a structural or optical confinement,
ZMW, or the like, is desired to stay within the interrogation
region, e.g., for a period less than the photodamage threshold
period. FIG. 6A shows a schematic illustration of a non-overlapping
step and repeat interrogation method using a circular illumination
spot. As shown, some portion of the substrate surface, indicated by
hatching, is not subjected to interrogation. In FIG. 6B, however, a
scanning or overlapping stepping process is used to interrogate
larger portions of the surface area.
[0050] FIG. 7 is a schematic illustration of an overall system 700
useful for performing the step and move operations on substrates in
accordance with certain aspects of the invention. As shown, a
reaction substrate 702 is disposed upon a translation stage 704.
Stage 704 is typically coupled to appropriate robotics
(schematically represented by armature 706) that provides lateral
translation of the substrate 702, in two dimensions (x and y) over
a fixed optical train 708. Although shown as being coupled to and
rendering the translation of the substrate, it will be appreciated
that alternative configurations could couple to translation system
to the optical train to move that aspect of the system relative to
the substrate. Optical train 708 may comprise a variety of
different configurations useful for interrogating the substrate,
including appropriate excitation light sources, e.g., laser 718,
focusing and filtering optics, e.g., dichroic mirror 720, objective
lens 710, imaging lens 712, prism 714, and detectors or detector
arrays, e.g., detector array 716. One example of a particularly
preferred optical train is described in commonly owned U.S. patent
application Ser. No. 11/201,768 filed Aug. 11, 2005, and
incorporated herein by reference in its entirety for all
purposes.
III. EXEMPLARY APPLICATIONS
[0051] As noted above, the methods and compositions of the
invention are useful in a broad range of optically detected
analytical reactions, and particularly those using photoluminescent
or fluorescent reactants, and particularly such reactions where the
reagents that are susceptible to photodamage are present at
relatively low levels. One exemplary application of the methods and
compositions described herein is in single molecule analytical
reactions, where the reaction of a single, or very limited number
of molecules are observed in the analysis, such as observation of
the action of a single enzyme molecule. In particular, when an
analysis is relying upon a small population of reagent molecules,
damage to any significant fraction of that population will have a
substantial impact on the analysis being performed.
[0052] One example of a single molecule analysis includes
sequencing of nucleic acids by observing incorporation of
nucleotides into a nascent nucleic acid sequence during template
directed polymerase based synthesis. Such methods, generally
referred to as "sequencing by incorporation," involve the
observation of the addition of nucleotides or nucleotide analogs in
a template dependent fashion in order to determine the sequence of
the template strand. A number of processes for performing this
detection include the use of fluorescently labeled nucleotide
analogs within a confined observation region, e.g., within a
nanoscale well or tethered, either directly or indirectly to a
surface. By illuminating and detecting the fluorescent bases that
are incorporated, or are to be incorporated into the nascent
strand, one can ascertain the nature of the base, and as a result,
the complementary base in the template strand.
[0053] One particularly preferred aspect of the invention is in
conjunction with the sequencing by incorporation of nucleic acids
within an optical confinement, such as a zero mode waveguide, in
which one is observing an extremely small reaction volume in which
one or only a few polymerase enzymes and their fluorescent
substrates may be present. Zero mode waveguides, and their use in
sequencing applications is generally described in U.S. Pat. No.
6,917,726, and preferred methods of sequencing by incorporation are
generally described in Published U.S. Patent Application No.
2003-0044781, the full disclosures of which are incorporated herein
by reference in their entirety for all purposes.
[0054] As will be appreciated, prolonged interrogation of a limited
population of reagents, e.g., fluorescent analogs and confined
polymerase enzymes can lead to photodamage of the various reagents
to the point of substantially impacting the activity or
functionality of the polymerase enzyme. In particular, it has been
shown that prolonged illumination of DNA polymerases involved in
synthesis using fluorescent nucleotide analogs results in a
dramatic decrease in the enzyme's ability to synthesize DNA.
Without being bound to any theory of operation, it is believed that
the photodamage event affects the catalytic region of the enzyme
thus affecting either the ability of the enzyme to remain complexed
with the template, or its ability to process additional
synthesis.
[0055] In accordance with the present invention, the
above-described sequencing reaction may be carried out in the
presence of one or more photodamage mitigating agents, as described
above. In preferred aspects, the sequencing reactions may be
carried out in the presence of both a reducing agent, such as DTT,
MEA or BME, and an oxygen scavenger, such as GO-Cat.
[0056] In general, the photodamage mitigating agents are present in
the reaction mixture at levels sufficient to provide beneficial
impact, e.g., reduced photodamage and/or extension of the
photodamage threshold period, but are not present at such levels as
to interfere with the reaction of interest, e.g., the sequencing
reaction. Concentrations of the components of a photodamage
mitigating agent will generally vary by application. By way of
example, reducing agents, such as DTT, MEA or BME, may generally be
present at amounts of between about 100 .mu.M and 500 mM, and
preferably between about 1 mM and about 200 mM, e.g., in some cases
about 5 mM for DTT and 100 mM for MEA, but may vary from these
concentrations. In the case of DTT, preferred concentrations range
from about 1 mM to about 10 mM, while preferred ranges for MEA may
be from about 10 mM to about 200 mM. Likewise, the concentration of
oxygen scavengers will generally vary depending upon the
application, the level of oxygen present, the susceptibility of the
system to reactive oxygen species, etc. For example, in sequencing
reactions, oxygen scavenging enzyme systems, e.g., GO-Cat, are
generally present at levels that provide effective oxygen
scavenging without excessively impairing the desired reactions,
e.g., polymerase activity. Typically, this includes concentrations
of GO-Cat reagents within the reaction mixture that are anywhere
from, e.g., up to about 5 .mu.M Glucose Oxidase and up to about 575
nM catalase, or 3 to 4 times typcal GO-Cat concentrations, down to
13 nM Glucose Oxidase and 1.5 nM catalase) or 0.01.times.GO-Cat
concentrations. Typically, the concentrations will be between about
0.01.times. to about 0.5.times. of typical GO-Cat concentrations as
set forth above, and more preferably including or between about
0.1.times. and 0.25.times.GO-Cat. For immobilized oxygen mitigation
systems, the amount of immobilized reagents will generally provide
activity levels that correspond to the activity levels of the
aforementioned concentrations in non-immobilized formats. Precise
amounts of reagents will generally depend upon the relative
efficiency of the immobilization process, and resulting activity of
the immobilized components.
[0057] The following non-limiting examples are provided to further
illuminate the invention.
IV. EXAMPLES
[0058] Because of the value of single molecule analysis in nucleic
acid sequencing applications, DNA polymerase systems were used to
identify the impact of photodamage and its solutions in accordance
with the present invention. Initial assays were run in three
different configurations to identify the scope and/or nature of
photodamage to polymerase reactions. These included a bulk DNA
synthesis experiment, a flat surface based nucleic acid synthesis
reaction, and synthesis within an array of zero mode
waveguides.
Example 1
Photodamage and Mitigation in Bulk Reaction Volumes
[0059] In a first assay, synthesis reaction mixtures contained a
modified .phi.29 DNA polymerase, 300 nM DNA template, three native
nucleoside triphosphates (at 10 .mu.M each) and a fluorescent dye
labeled nucleoside polyphosphate (at 10 .mu.M) in synthesis buffer
(50 mM Tris-HCl, pH 7.5, 75 mM KCL, 20 mM (NH.sub.4).sub.2SO.sub.4,
10 mM BME, 0.7 mM MnCl.sub.2). Each of the reactions were carried
out at room temperature (22.degree. C.) for the desired
illumination period, ranging from 1 minute to one hour.
[0060] The experiment included two sets each of three different
reaction mixtures: (1) a synthesis reaction using only native,
e.g., unlabeled nucleoside triphosphates; (2) a synthesis reaction
including two native nucleoside triphosphates, an Alexa 488 labeled
dCTP analog, and an Alexa 568 labeled dTTP; and (3) a synthesis
reaction including two native nucleoside triphosphates, an Alexa
488 labeled dC4P analog (tetraphosphate), and an Alexa 568 labeled
dT4P. Each different synthesis reaction conditions included either
no illumination or laser illumination during synthesis for five
minutes with wavelengths of 488, 568 and 647 nm, followed by 60
minutes of nonilluminated synthesis.
[0061] Following synthesis, the reaction products were separated on
a 0.7% agarose gel under standard conditions. FIG. 2A provides an
image of the Sybr.RTM.Gold stained gel. As shown, lane 1 on the
left, includes a molecular weight standard. The next two lanes (3
and 4, lane 2 is empty)) include the synthesis reaction including
only unlabelled nucleoside triphosphates (reaction conditions 1,
above), in the absence of laser illumination (-) and with laser
illumination (+). Moving to the next two lanes to the right (5 and
6) include similar reactions, but including labeled nucleoside
triphosphates (reaction condition 2, above), while the right most
lanes (7 and 8) include the labeled nucleoside tetraphosphate
analogs in the synthesis reaction (reaction condition 3, above)(For
a discussion of phosphate labeled nucleoside polyphosphates, see,
e.g., U.S. Pat. No. 6,399,335, and published U.S. Patent
Application No. 2003/0124576, the full disclosures of which are
incorporated herein by reference for all purposes).
[0062] As can be seen from the gel, a large amount of relatively
high molecular weight DNA has been synthesized in the native
reaction, both with and without laser illumination. In each of the
cases utilizing labeled analogs, the amount and relative size of
the synthesized DNA is less than native conditions. Of particular
note, however, is that in each of these latter two reactions, the
laser illumination results in a substantial decrease in the amount
of higher molecular weight DNA produced. Of further note, despite
that reaction conditions are identical for reaction conditions 2
and 3, except for the use of tetraphosphate analogs, the amount of
lost DNA synthesis in the illuminated sample is proportionately
greater in the labeled triphosphate reaction. This is indicated by
the ratio of DNA in the Illuminated sample to the nonilluminated
sample for each reaction condition (as determined by image
scanning). In particular, the ratio DNA quantity in the gel lane of
illuminated to nonilluminated in the native reaction conditions is
approximately 1 (1.10). When the reaction includes labeled
triphosphate analogs, this ratio drops to 0.27, while the use of
tetraphosphate analogs drops this ratio to 0.56. These data are
suggestive that the photodamage effects may be caused by proximity
or length of retention time of the fluorophor to the active site of
the enzyme during illumination. This interpretation was
strengthened by similar experiments performed with unlabeled
nucleoside triphosphates, that were spiked with free dyes, e.g.,
not coupled to the analog, that showed little or no impact of
illumination on synthesis.
[0063] Similarly, synthesis reactions using fluorescent analogs
that were illuminated at a nonexciting wavelength showed little or
no impact on polymerase activity, again, indicating that the
excited and/or fluorescing analog mediated the damage to the
polymerase activity in some measure. The various above-described
experiments indicated that photodamage was greatest in the
reactions that included the Alexa568 dye labeled nucleotide
analogs, further bolstering the suggested photophysical effect, as
the Alexa568 dye is reported to be less photostable than the Alexa
488 dye. Additional experiments using non-incorporatable dye
labeled analogs, e.g., not complementary to any base in the
template, provided little or no measurable photodamage. All of the
foregoing provides further apparent indication that the impact on
polymerase activity results from the presence of an excited dye
labeled nucleotide (or nucleotide analog) within the active site of
the polymerase enzyme, indicating some damage to the enzyme or
irreversible interaction at the active site.
[0064] The experiments using dye labeled tetraphosphates (reaction
condition 3, above) were repeated using three different mitigation
treatments: (1) 10 mM .beta.ME (standard conditions or negative
control); (2) 5 mM DTT; and (3) 100 mM MEA, with and without laser
illumination as described above. Again, the synthesis products were
separated on an agarose gel, an image of which is shown in FIG. 2B.
The gel was subjected to image scanning (Molecular Dynamics Typhoon
9400, with Typhoon scanner Control Version 2; gel image quantified
with Molecular Dynamiics ImageQuant ver. 5.2). The results of this
analysis showed that in the absence of any change from standard
conditions, e.g., including only 10 mM .beta.ME, the ratio of
product when exposed to laser illumination to that in the absence
of such illumination was 0.24. When DTT was added to the reaction
mixture, the ratio improved to 0.59, while addition of MEA appeared
to provide complete or substantially complete protection (a ratio
of 1.04) against photo-induced damage from a 5 minute illumination.
These data demonstrate that the use of reducing agents as
photodamage mitigating agents appear to prevent loss of polymerase
activity that occurs during synthesis that is occurring under laser
excitation illumination.
Example 2
Photodamage and Mitigation in Surface Immobilized Enzyme
Systems
[0065] Next, a GST-tagged .phi.29 polymerase was coated on the
surface of a fused silica microscope slide, by depositing the
polymerase over the slide and incubating the surface for 15 minutes
on ice. Template dependent synthesis of DNA was carried out on the
surface using native nucleotides and 10 .mu.M Alexa488-labeled-dC4P
and Alexa568-labeled-dT4P, while illuminating a small semi-circular
shaped laser spot on the slide. The only reducing agent present in
the mixture was 10 mM PME. The slides were exposed to laser
illumination at 488 nm (1.1 mW) and 568 nm (1.8 mW) with different
positions being illuminated for 1 minute and for 5 minutes.
Following illumination, synthesis was allowed to continue for 60
minutes using only native nucleotides. The slides were stained for
the presence of synthesized DNA using Sybr-gold. Images of the
illuminated slides after 1 minute and 5 minutes are shown in FIG.
3A. As can be seen, the semicircular illumination region is devoid
of any synthesized DNA after only 1 minute of illumination, and the
impact is shown to be greater after 5 minutes of illumination.
[0066] As synthesis was lacking even when non-illuminated synthesis
was allowed to proceed for 60 minutes, it is indicative not only of
photodamage to polymerase activity, but also that such damage is
apparently lasting or even permanent.
[0067] A similar experiment was carried out in the presence of
different mixtures of photodamage mitigating agents or
concentrations thereof. In particular, as with Example 1, above,
three different reaction mixtures were used that included different
mitigation treatments: (1) 10 mM .beta.ME (standard conditions or
negative control)(same as shown in FIG. 3A); (2) 100 mM MEA; and
(3) 100 mM MEA, 5 mM DTT and 1.times.GO Cat (1.3 .mu.M Glucose
Oxidase and 150 nM catalase). The results are shown in FIG. 3B. As
can be seen, the reactions that included MEA showed a dramatic
decrease in the burned in image indicative of damaged polymerase
activity, in both 1 minute and 5 minute illumination experiments.
The addition of DTT and GO-Cat further reduced the level of damage
to polymerase activity to the point that it was not discernible in
the 1 minute exposure, and was barely discernible after 5 minutes
exposure.
[0068] While the presence of GO-Cat provides a substantial
elimination of photodamage, the presence of relatively high
concentrations of these proteins may have adverse effects on
certain applications, e.g., where such reactions are based on
relatively low levels of reactants, as such protein can mask, block
or otherwise inhibit reactions of interest. As such, an additional
experiment was carried out to determine effective reduced levels
for the various photodamage mitigating agents on a pretreated
surface. Briefly, a surface treated to provide selective polymerase
immobilization was prepared and used for the titration experiments
on the concentrations of GO-Cat. The experimental set up is set
forth below.
[0069] A. Surface Preparation
[0070] Neutravidin was diluted at 1 mg/ml to 0.2 mg/ml in a
solution of 1.times. BFA (0.05% Tween20, 150 mM KCl, 25 mM Tris-HCl
pH 7.5, 5 mM DTT). Biotin-GST tagged .phi.29 polymerase was diluted
to a concentration of approximately 128 nM in 1.times.BFA, and
equal volumes of the neutravidin solution and polymerase solution
were combined and incubated at 23.degree. C. for 30 minutes.
[0071] The neutravidin-polymerase mixture was then placed onto a
gasketed fused silica slide having a PEG24-Biotin modified surface,
and covered with a cover slip. The slide was then incubated for 1
hour at 23.degree. C. Following incubation, the slide was washed 3
times in 1.times.BFA.
[0072] B. Synthesis/Illumination Experiments
[0073] The GO-Cat reagents were used to dilute with 2.times.MM
reagent (2.times.prb-BME (100 mM Tris-HCl pH 7.5, 40 mM ammonium
sulfate, 150 mM KCl), 200 mM MEA, 10 mM DTT, 0.4% glucose, 1.4 mM
MnCl.sub.2, 300 nM CL31 circular template, 20 .mu.M A488 dC4P, 20
.mu.M A568 dT4P, 20 .mu.M dATP and dGTP), 1:1 to yield final
reaction mixtures having 100 mM MEA, 5 mM DTT, and 0, 0.02.times.,
0.05.times. and 0.1.times.GO-CAT reagent. These diluted synthesis
reagents (diluted 2.times.MM with and without GO-CAT) were then
deposited onto the gasketed slide, which was then illuminated at a
suitable location with laser spots at 488 nm and 568 nm, for 5
minutes. Following laser illumination, the reaction mixture was
replaced with the 1.times. postMM reagent (1.times. prb-BME (50 mM
Tris-HCl pH 7.5, 20 mM ammonium sulfate, 75 mM KCl), 100 nM CL31
circular template, 0.7 mM MnCl2, 2 .mu.M A488-dUTP, 8 .mu.M dTTP,
10 .mu.M dATP, dCTP and dGTP) and incubated at 23.degree. C. for 60
minutes without illumination. The resulting slide was washed twice
with 1.times.BFA and stained with Sybr.RTM. Gold intercalating dye,
and imaged. The resulting images are shown in FIG. 3C. As can be
seen, use of exceedingly low levels of GO-Cat provides beneficial
impact on polymerase activity. However, the presence of the GO-Cat
reagents at approximately 0.1.times. the standard concentration
provides nearly complete elimination of polymerase activity damage.
The image data was then plotted (FIG. 3D) as a function of
background normalized crater intensity volume vs. GO-Cat
concentration. Again, suitable protection appears to be achieved at
the relatively low added protein level of 0.1.times.GO-Cat.
Example 3
Photodamage and Mitigation on Nanostructured Reactive Surfaces
[0074] A similar set of experiments to those described above were
performed using DNA polymerase immobilized within zero mode
waveguides in an array of waveguides. As above, the first
experiment was designed to identify whether laser illumination
caused damage to immobilized polymerase enzymes on nanostructured
surfaces. The surfaces included ZMW arrays in which the polymerase
enzyme was adsorbed to the surface. DNA synthesis using dye labeled
nucleoside tetraphosphates (Alexa488dC4P and Alexa568dT4P) was
carried out with and without laser illumination (at 488 and 568 nm)
and the resulting product was again stained with Sybr.RTM. Gold.
Images of the arrays are shown in FIG. 4A. The illumination profile
is shown in the first panel (far left), while the image of the
stained DNA product in the illuminated synthesis is shown in the
adjacent panel (middle left). As can be seen, a negative image is
apparent in the illuminated region corresponding to the
illumination pattern. The middle right and far right panels show
non-illuminated waveguide arrays, and indicate substantially more
DNA is present than in the illuminated sample, again showing
photo-induced damage to the polymerase activity in the waveguide
arrays.
[0075] FIG. 4B illustrates a first set of waveguide arrays in which
similar synthesis reactions were carried out in the presence of no
additional mitigation agents (e.g., only 10 mM .beta.ME), or in the
presence of 5 mM DTT and 100 mM MEA. As can be seen addition of the
DTT and MEA provides substantial protection against damage to
polymerase activity caused by laser illumination, and appears to
give reactions that produce substantially equivalent amounts of DNA
product as the non-illuminated arrays. Additional experiments also
showed improvements in the amount of damaged polymerase activity in
the presence of 160 mM DTT, without MEA, although not as pronounced
as in the presence of 5 mM DTT and 100 mM MEA.
[0076] Although described in some detail for purposes of
illustration, it will be readily appreciated that a number of
variations known or appreciated by those of skill in the art may be
practiced within the scope of present invention. Unless otherwise
clear from the context or expressly stated, any concentration
values provided herein are generally given in terms of admixture
values or percentages without regard to any conversion that occurs
upon or following addition of the particular component of the
mixture. To the extent not already expressly incorporated herein,
all published references and patent documents referred to in this
disclosure are incorporated herein by reference in their entirety
for all purposes.
* * * * *